维普中文期刊产品整合服务
13篇 您的检索式:作者名="Kierstead LS"
    题名 作者 年代 出处 被引量
1Dendritic cell/peptide cancer vaccines: clinical responsiveness and epitope spreading 显示文摘Ranieri E Kierstead LS Zarour H 2000Immanol Invest2000,,:1
2Dendritic cell peptide cancer vaccines:clinical responsiveness and epitope spreading显示文摘Ranieri E Kierstead LS Zarour H 2000Immunol Invest2000,29,2:1
3MelanA/MART151-73 represents an immunogenic HLA-DR4-restricted epitope recognized by melanoma-reactive CD4+ T cells显示文摘 Kirkwood JM Kierstead LS 2000Proc Natl Acad Sci USA2000,97,:1
4Memory T cells and vaccines显示文摘Esser MT Marchese RD Kierstead LS 2003Vaccine2003,21,56:1
5MelanA/MART151-73 represents an immunogenic HLA-DR4-restricted epitope recognized by melanoma-reactive CD4 + T cells 显示文摘 Kirkwood JM Kierstead LS 2000Proc Natl Acad Sci USA2000,97,:1
6Dendritic cell/peptide cancervaccines:clinical responsiveness and epitope spreading 显示文摘Ranieri E Kierstead LS Zarour H 2000ImmunolInvest2000,29,2:1
7Disease-associated bias in T helper type1(Th1)/Th2CD 4+T cell responses against MAGE-6in HLA-DRB10401patients with renal cell carcinoma or melano-ma显示文摘Tatsumi T Kierstead LS Ranieri E 2002J Exp Med2002,196,5:1
8Comparative cell-mediated immunogenicity of DNA/DNA, DNA/adenovirus type 5 (Ad5), or Ad5/Ad5 HIV-1 clade B gag vaccine prime-boost regimens 显示文摘Asmuth DM Brown EL DiNubile MJ Sun X del Rio C Harro C Keefer MC Kublin JG Dubey SA Kierstead LS Casimiro DR Shiver JW Robertson MN Quirk EK Me- hrotra DV 2010J In- fect Dis2010,201,1:1
9Melan-A/MART- 1(51-73) represents an immunogenic HLA-DR4-restricted epitope recognized by melanoma-reactive CD4(+) T cells显示文摘Zarour HM Kirkwood JM Kierstead LS 2000Proc Natl Acad Sci2000,97,1:1
10Dendtritic cell/peptide cancer vaccines:clinical responsiveness and epitope spreading显示文摘Ranieri E Kierstead LS Zarour H 2000Immunol Invest2000,29,2:1
11Memory T cells and vaccines显示文摘Esser MT Marchese RD Kierstead LS 2003Vaccine2003,21,56:1
12Dendritic cell/peptide cancer vaccine= clinical responsiveness and epitope spreading显示文摘Ranieri E Kierstead LS Zarour H 2000Immunol Invest2000,29,2:1
13Dendritic cell/peptide cancer vaccines : clinical responsiveness and epitope spreading 显示文摘Ranieri E Kierstead LS Zarour H 2000Immunol Invest2000,29,2:1
返回顶部 每页显示:
共1页 首页 上一页 第1页 下一页 末页 /1 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费